Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. 2010

Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
Laboratory of Human Bacterial Pathogenesis, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.

Mechanisms underlying the enhanced virulence phenotype of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are incompletely defined, but presumably include evasion of killing by human polymorphonuclear leukocytes (PMNs or neutrophils). To better understand this phenomenon, we investigated the basis of rapid PMN lysis after phagocytosis of USA300, a prominent CA-MRSA strain. Survival of USA300 clinical isolates after phagocytosis ultimately resulted in neutrophil lysis. PMNs containing ingested USA300 underwent morphological changes consistent with apoptosis, but lysed rapidly thereafter (within 6 h), whereas cells undergoing FAS-mediated apoptosis or phagocytosis-induced cell death remained intact. Phagosome membranes remained intact until the point of PMN destruction, suggesting lysis was not caused by escape of S. aureus from phagosomes or the cytolytic action of pore-forming toxins. Microarray analysis of the PMN transcriptome after phagocytosis of representative community-associated S. aureus and healthcare-associated MRSA strains revealed changes unique to community-associated S. aureus strains, such as upregulation of transcripts involved in regulation of calcium homeostasis. Collectively, the data suggest that neutrophil destruction after phagocytosis of USA300 is in part a form of programmed necrosis rather than direct lysis by S. aureus pore-forming toxins. We propose that the ability of CA-MRSA strains to induce programmed necrosis of neutrophils is a component of enhanced virulence.

UI MeSH Term Description Entries
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D010588 Phagosomes Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material. Phagolysosomes,Phagolysosome,Phagosome
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired

Related Publications

Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
April 1981, The veterinary quarterly,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
January 2014, Frontiers in immunology,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
October 1991, Journal of dairy science,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
December 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
September 1987, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
March 2002, The Journal of biological chemistry,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
December 1994, Infection and immunity,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
January 2000, Veterinary research,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
December 1977, Applied and environmental microbiology,
Scott D Kobayashi, and Kevin R Braughton, and Amy M Palazzolo-Ballance, and Adam D Kennedy, and Elizabeth Sampaio, and Ervand Kristosturyan, and Adeline R Whitney, and Daniel E Sturdevant, and David W Dorward, and Steven M Holland, and Barry N Kreiswirth, and James M Musser, and Frank R DeLeo
January 2005, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
Copied contents to your clipboard!